01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Directory 07Corporate Insiders 08Government Money 09Political Influence 10Institutions 11Washington Network 12Follow the Power 13Disclosure Clock 14AI Investigator 15Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Directory 07Corporate Insiders 08Government Money 09Political Influence 10Institutions 11Washington Network 12Follow the Power 13Disclosure Clock 14AI Investigator 15Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

SEC FORM 452m ago

HOUSE PTR52m ago

SEC 13F52m ago

ROBINHOOD CHAIN52m ago

Public company

FULCFulcrum Therapeutics, Inc.

CIK 0001680581

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections2with evidence

FULC · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
THE MCMANUS GROUPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026

Lobbying

$110K reported · de-duplicated

2026 Q2 $60K via firms2026 Q1 $50K via firms

THE MCMANUS GROUP$50K2026 Q1 · posted Aug 26, 2026 · Health issues
THE MCMANUS GROUP$60K2026 Q2 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.